Titan Pharmaceuticals Stock Analysis

Titan Stock Analysis Notes

About 45.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Titan Pharmaceuticals recorded a loss per share of 7.41. The entity last dividend was issued on the 1st of December 2020. The firm had 1:20 split on the 9th of January 2024. Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. The company was incorporated in 1992 and is based in South San Francisco, California. Titan Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To find out more about Titan Pharmaceuticals contact the company at 650 244 4990 or learn more at https://www.titanpharm.com.

Titan Pharmaceuticals Investment Alerts

Titan Pharmaceuticals Upcoming and Recent Events

Titan Largest EPS Surprises

View All Earnings Estimates

Titan Stock Institutional Investors

Note, although Titan Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Titan Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Titan Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Titan Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Titan Profitablity

Management Efficiency

Titan Pharmaceuticals has return on total asset (ROA) of (0.749) % which means that it has lost $0.749 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3914) %, meaning that it created substantial loss on money invested by shareholders. Titan Pharmaceuticals' management efficiency ratios could be used to measure how well Titan Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/24/2024, Return On Tangible Assets is likely to drop to -0.72. In addition to that, Return On Capital Employed is likely to drop to -1.15. As of 04/24/2024, Non Current Liabilities Other is likely to grow to about 1 M, while Total Current Liabilities is likely to drop slightly above 1.4 M.

Technical Drivers

As of the 24th of April, Titan Pharmaceuticals has the Coefficient Of Variation of 1700.07, semi deviation of 5.59, and Risk Adjusted Performance of 0.0457. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Titan Pharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Titan Pharmaceuticals, which can be compared to its competition. Please validate Titan Pharmaceuticals jensen alpha and semi variance to decide if Titan Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 6.97 per share. Given that Titan Pharmaceuticals has jensen alpha of 0.4259, we advise you to double-check Titan Pharmaceuticals's current market performance to make sure the company can sustain itself at a future point.

Titan Pharmaceuticals Price Movement Analysis

Titan Pharmaceuticals Insider Trading Activities

Titan Pharmaceuticals Predictive Daily Indicators

Titan Pharmaceuticals Corporate Filings

Titan Pharmaceuticals Forecast Models

Titan Pharmaceuticals' time-series forecasting models are one of many Titan Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Titan Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Titan Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Titan shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Titan Pharmaceuticals. By using and applying Titan Stock analysis, traders can create a robust methodology for identifying Titan entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Titan analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Titan analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Titan Pharmaceuticals stock analysis indicators help investors evaluate how Titan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Titan Pharmaceuticals shares will generate the highest return on investment. By understating and applying Titan Pharmaceuticals stock analysis, traders can identify Titan Pharmaceuticals position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.